Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Platelet-Rich Plasma for Venous Leg Ulcers in Primary Care (Phase III)
2014-001514-26Phase 3Completed
- Sponsor
- OSI Ezkerraldea Enkarterri Cruces
- Start
- Jun 2014
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 3 trial of autologous platelet-rich plasma in stasis ulcer and venous stasis (2 arms), sponsored by OSI Ezkerraldea Enkarterri Cruces. Primary endpoint: Ulcer size change. Started Jun 2014; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
stasis ulcervenous stasis
Beyond the preview
Go deeper on 2014-001514-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001514-26.